Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients

British Journal of Haematology

Volumn 174, Issue 6, 2016, Pages 923-931

  Maeshima, Akiko Miyagi ^a   Taniguchi, Hirokazu ^a   Toyoda, Kosuke ^a   Yamauchi, Nobuhiko ^a   Makita, Shinichi ^a   Fukuhara, Suguru ^a   Munakata, Wataru ^a   Maruyama, Dai ^a   Kobayashi, Yukio ^a   Tobinai, Kensei ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

diffuse large B cell lymphoma; immunohistochemistry; mucosa associated lymphoid tissue lymphoma; outcome; transformation

Indexed keywords

CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; EYE TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MARGINAL ZONE LYMPHOMA; OCULAR ADNEXA TUMOR; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STOMACH CANCER;

EID: 84986004487     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14153     Document Type: Article

References (19)

1. Al-Tourah, A.J., Gill, K.K., Chhanabhai, M., Hoskins, P.J., Klasa, R.J., Savage, K.J., Sehn, L.H., Shenkier, T.N., Gascoyne, R.D. & Connors, J.M. (2008) Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. Journal of Clinical Oncology, 26, 5165–5169.
2. Cheson, B.D., Pfistner, B., Juweid, M.E., Gascoyne, R.D., Specht, L., Horning, S.J., Coiffier, B., Fisher, R.I., Hagenbeek, A., Zucca, E., Rosen, S.T., Stroobants, S., Lister, T.A., Hoppe, R.T., Dreyling, M., Tobinai, K., Vose, J.M., Connors, J.M., Federico, M. & Diehl, V.; International Harmonization Project on Lymphoma (2007) Revised response criteria for malignant lymphoma. Journal of Clinical Oncology, 25, 579–586.
3. Conconi, A., Franceschetti, S., Aprile von Hohenstaufen, K., Margiotta-Casaluci, G., Stathis, A., Moccia, A.A., Bertoni, F., Ramponi, A., Mazzucchelli, L., Cavalli, F., Gaidano, G. & Zucca, E. (2015) Histologic transformation in marginal zone lymphomas. Annals of Oncology, 26, 2329–2335.
4. Davies, A.J., Rosenwald, A., Wright, G., Lee, A., Last, K.W., Weisenburger, D.D., Chan, W.C., Delabie, J., Braziel, R.M., Campo, E., Gascoyne, R.D., Jaffe, E.S., Muller-Hermelink, K., Ott, G., Calaminici, M., Norton, A.J., Goff, L.K., Fitzgibbon, J., Staudt, L.M. & Andrew Lister, T. (2007) Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. British Journal of Haematology, 136, 286–293.
5. Flossbach, L., Antoneag, E., Buck, M., Siebert, R., Mattfeldt, T., Möller, P. & Barth, T.F.E. (2011) BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. International Journal of Cancer, 129, 70–77.
6. Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Müller-Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. & Chan, W.C. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275–282.
7. Isaacson, P.G., Chott, A., Nakamura, S., Muller-Hermelink, H.K., Harris, N.L. & Swerdlow, S.H. (2008) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: WHO classification of tumours of haematopoietic and lymphoid tissues (ed. by Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W.), pp. 214–217. IARC, Lyon.
8. Jaffe, E.S., Harris, N.L., Stein, H., Campo, E., Pileri, S.A. & Swerdlow, S.H. (2008) Introduction and overview of the classification of the lymphoid neoplasms. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn (ed. by Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W.), pp. 158–166. International Agency for Research on Cancer, Lyon.
9. Kridel, R., Mottok, A., Farinha, P., Ben-Neriah, S., Ennishi, D., Zheng, Y., Chavez, E.A., Shulha, H.P., Tan, K., Chan, F.C., Boyle, M., Meissner, B., Telenius, A., Sehn, L.H., Marra, M.A., Shah, S.P., Steidl, C., Connors, J.M., Scott, D.W. & Gascoyne, R.D. (2015) Cell of origin of transformed follicular lymphoma. Blood, 126, 2118–2127.
10. Maeshima, A.M., Omatsu, M., Nomoto, J., Maruyama, D., Kim, S.W., Watanabe, T., Kobayashi, Y., Tobinai, K. & Matsuno, Y. (2008) Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses. Cancer Science, 99, 1760–1768.
11. Maeshima, A.M., Taniguchi, H., Fukuhara, S., Maruyama, D., Kim, S.W., Watanabe, T., Kobayashi, Y., Tobinai, K. & Tsuda, H. (2013) Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma. Cancer Science, 104, 952–957.
12. Meyer, A.H., Strouz, A., Lerch, K., Eucker, J., Eitle, J., Hohloch, K., Andrzejak, M., Possinger, K., Dörken, B., Pezzutto, A. & Scholz, C.W. (2014) Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma. Annals of Oncology, 25, 210–215.
13. Montoto, S., Davies, A.J., Matthews, J., Calaminici, M., Norton, A.J., Amess, J., Vinnicombe, S., Waters, R., Rohatiner, A.Z. & Lister, T.A. (2007) Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. Journal of Clinical Oncology, 25, 2426–2433.
14. Olszewski, A.J. & Castillo, J.J. (2013) Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer, 119, 629–638.
15. Radaszkiewicz, T., Dragosics, B. & Bauer, P. (1992) Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology, 102, 1628–1638.
16. Rossi, D., Cerri, M., Capello, D., Deambrogi, C., Rossi, F.M., Zucchetto, A., De Paoli, L., Cresta, S., Rasi, S., Spina, V., Franceschetti, S., Lunghi, M., Vendramin, C., Bomben, R., Ramponi, A., Monga, G., Conconi, A., Magnani, C., Gattei, V. & Gaidano, G. (2008) Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. British Journal of Haematology, 142, 202–215.
17. Thieblemont, C., Bastion, Y., Berger, F., Rieux, C., Salles, G., Dumontet, C., Felman, P. & Coiffier, B. (1997) Mucosa-associated lymphoid tissue gastrointestinal and non-gastrointestinal lymphoma behavior: analysis of 108 patients. Journal of Clinical Oncology, 15, 1624–1630.
18. Tsuboi, K., Iida, S., Inagaki, H., Kato, M., Hayami, Y., Hanamura, I., Miura, K., Harada, S., Kikuchi, M., Komatsu, H., Banno, S., Wakita, A., Nakamura, S., Eimoto, T. & Ueda, R. (2000) MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia, 14, 449–456.
19. Zucca, E., Conconi, A., Laszlo, D., López-Guillermo, A., Bouabdallah, R., Coiffier, B., Sebban, C., Jardin, F., Vitolo, U., Morschhauser, F., Pileri, S.A., Copie-Bergman, C., Campo, E., Jack, A., Floriani, I., Johnson, P., Martelli, M., Cavalli, F., Martinelli, G. & Thieblemont, C. (2013) Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. Journal of Clinical Oncology, 31, 565–572.